Michael Quirk
Tracked across 1 events · 6 articles · First seen Jun 11, 2026 · Last active Jun 11, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Michael Quirk>>> was appointed Senior Advisor for the sepranolone program at Relmada Therapeutics>>>, bringing over 20 years of neuroscience drug development experience to the role. His expertise is crucial for advancing the program.
Jun 11, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Michael Quirk live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard